Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-13

Clinical Trial Update: Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluated pre-operative olanzapine as a prophylactic antiemetic in oncologic patients undergoing surgery, with completion repor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Postoperative Nausea, Postoperative Nausea and Vomiting | Phase 2, Phase 3 | Status: COMPLETED